Browse All

Current Filters

CLEAR FILTER x

TITLE

Impact of 24-hour Subcutaneous Levodopa/Carbidopa Infusion (ND0612) on Motor Function: Efficacy Outcomes from the Phase 3 BouNDless Study

Author:Ellenbogen, Aaron L.   Espay, Alberto J.   Hauser, Robert A.   Stocchi, Fabrizio   Pahwa, Rajesh   Ferreira, Joaquim J.   Kieburtz, Karl   Albanese, Alberto   Giladi, Nir   Salin, Laurence   Sasson, Nissim   Adar, Liat   Vostokova, Natalia   Pereira, Jonathan   Rascol, Olivier   

Session Name:S37: Movement Disorders: Clinical Trials  

Topic:Movement Disorders  

Program Number:S37.001  

Author Institution:Quest Research Institute, Farmington Hills, MI  James J. and Joan A. Gardner Center for Parkinson’s Disease and Movement Disorders, University of Cincinnati, Cincinnati, OH  University of South Florida, Tampa, FL  University San Raffaele Roma and Institute for Research and Medical Care IRCCS San Raffaele, Roma, Italy  University of Kansas Medical Center, Kansas City, KS  Laboratory of Clinical Pharmacology and Therapeutics, Faculdade de Medicina, Universidade de Lisboa, Lisboa, Portugal  Clintrex Research Corp, Sarasota, FL  Department of Neurology, IRCCS Istituto Clinico Humanitas, Rozzano, Italy  Brain Institute, Tel-Aviv Medical Center Faculty of Medicine, Sagol School of Neurosciences, Tel Aviv University, Tel Aviv, Israel  NeuroDerm Ltd., Rehovot, Israel  Mitsubishi Tanabe Pharma America, Inc., Jersey City, NJ  University of Toulouse 3, University Hospital of Toulouse, INSERM, Clinical Investigation Center CIC1436, Toulouse, France  

Quality of Life with 24-hour Subcutaneous Levodopa/Carbidopa Infusion (ND0612): QoL Results from a Phase 3 Randomized, Active-controlled Study

Author:Sarva, Harini   Tagliati, Michele   Poewe, Werner   Stocchi, Fabrizio   Rascol, Olivier   Yardeni, Tami   Lopes, Nelson   Pereira, Jonathan   Espay, Alberto   

Session Name:P11: Movement Disorders: Therapeutics in Study for Parkinson's Disease  

Topic:Movement Disorders  

Program Number:P11.007  

Author Institution:Weill Cornell Medical Center, New York, NY  Cedars-Sinai Medical Center, Movement Disorder Program, Los Angeles, CA  Department of Neurology, Medical University Innsbruck, Innsbruck, Austria  University San Raffaele Roma and Institute for Research and Medical Care IRCCS San Raffaele, Rome, Italy  University of Toulouse 3, University Hospital of Toulouse, INSERM  Clinical Investigation Center CIC1436 Departments of Neurosciences and Clinical Pharmacology and NS-Park/FCRIN network, Toulouse, France  NeuroDerm Ltd. , Rehovot, Israel  Mitsubishi Tanabe Pharma America, Inc., Jersey City, NJ  James J and Joan A Gardner Center for Parkinson’s disease and Movement, University of Cincinnati, Cincinnati, OH